Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AKTX

Akari Therapeutics Plc ADR

May 29 • 04:00PM ET

16.43

-5.62 -25.49 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: IKT NBP NERV NVCT ALXO BCYC CGEN FATE FHTX CDXS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-18.86	Insider Own	0.40%	Shs Outstand	1.14M	Perf Week	219.65%
Market Cap	18.73M	Forward P/E	-	EPS next Y	-4.68	Insider Trans	0.00%	Shs Float	1.14M	Perf Month	213.55%
Enterprise Value	16.63M	PEG	-	EPS next Q	-1.33	Inst Own	5.91%	Short Float	5.67%	Perf Quarter	73.90%
Income	-28.00M	P/S	-	EPS this Y	72.10%	Inst Trans	-39.16%	Short Ratio	0.09	Perf Half Y	-7.90%
Sales	0.00M	P/B	1.31	EPS next Y	18.89%	ROA	-66.00%	Short Interest	0.06M	Perf YTD	42.13%
Book/sh	12.56	P/C	6.62	EPS next 5Y	32.82%	ROE	-155.01%	52W High	56.80 -71.07%	Perf Year	-68.40%
Cash/sh	2.48	P/FCF	-	EPS past 3/5Y	- -	ROIC	-194.71%	52W Low	3.02 444.94%	Perf 3Y	-88.90%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	70.06% 33.34%	Perf 5Y	-98.86%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	13.85%	Oper. Margin	-	ATR (14)	3.56	Perf 10Y	-99.86%
Dividend Ex-Date	-	Quick Ratio	0.27	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	64.44	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.27	EPS Q/Q	-75.83%	SMA20	104.64%	Beta	1.62	Target Price	33.50
Payout	-	Debt/Eq	0.05	Sales Q/Q	-	SMA50	162.69%	Rel Volume	0.71	Prev Close	22.05
Employees	6	LT Debt/Eq	0.00	Earnings	Apr 07	SMA200	-6.25%	Avg Volume	759.77K	Price	16.43
IPO	May 07, 2013	Option/Short	No / No	EPS/Sales Surpr.	-66.11% -	Trades		Volume	540,523	Change	-25.49%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)